jam
Chriitment, tipikali di antipaakinsn medikieshan L-DOPA ah duopamiin aganis, impruuv di hoerli simtomdem a di diziiz. Az di diziiz progres ah nyuurandem kantiniu fi laas, demaya medikieshan bikoms inifektiv wails a di sieh taim deh projuus wah komplikieshan maak bai invalinteri raidin muuvment.
eng
Treatments, typically the antiparkinson medications L-DOPA and dopamine agonists, improve the early symptoms of the disease. As the disease progresses and neurons continue to be lost, these medications become ineffective while at the same time produce a complication marked by involuntary writhing movements.